✦ LIBER ✦

Clinical trial: pharmacodynamics and pharmacokinetics of re-treatment with fixed-dose induction of peginterferon α-2a in hepatitis C virus genotype 1 true non-responder patients

✍ Scribed by M. DIAGO; J. CRESPO; A. OLVEIRA; R. PÉREZ; R. BÁRCENA; J. M. SÁNCHEZ-TAPIAS; M. MUÑOZ-SÁNCHEZ; M. ROMERO-GÓMEZ

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Controlled Trial of Danoprevi

✍ Marcellin, Patrick; Cooper, Curtis; Balart, Luis; Larrey, Dominique; Box, Terry; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 517 KB

Dose comparison study of pegylated inter

✍ Tomokazu Kawaoka; Yoshiiku Kawakami; Keiji Tsuji; Hiroyuki Ito; Mikiya Kitamoto; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

Combination therapy of thymalfasin (thym

✍ VINOD RUSTGI 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB

Induction doses of interferon-α-2a in co

✍ J. Salmerón; M. Diago; R. Andrade; R. Pérez; R. Solá; M. Romero; M. De La Mata; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

The results of a randomized trial lookin

✍ C. Brandão; A. Barone; F. Carrilho; A. Silva; M. Patelli; C. Caramori; R. Focacc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

751d SVR Results of Prove3, a Phase 2B C

✍ Adrian M. Di Bisceglie; Andrew M.J. Muir; Nathalie Adda; Ira M. Jacobson; Nezam 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 146 KB